| 17772-122-01 |
17772-122 |
HUMAN PRESCRIPTION DRUG |
OXTELLAR XR |
OXCARBAZEPINE |
TABLET |
ORAL |
20130117 |
N/A |
NDA |
NDA202810 |
Supernus Pharmaceuticals, Inc. |
OXCARBAZEPINE |
300 mg/1 |
100 TABLET in 1 BOTTLE (17772-122-01) |
| 17772-122-07 |
17772-122 |
HUMAN PRESCRIPTION DRUG |
OXTELLAR XR |
OXCARBAZEPINE |
TABLET |
ORAL |
20230701 |
N/A |
NDA |
NDA202810 |
Supernus Pharmaceuticals, Inc. |
OXCARBAZEPINE |
300 mg/1 |
7 TABLET in 1 BOTTLE (17772-122-07) |
| 17772-122-10 |
17772-122 |
HUMAN PRESCRIPTION DRUG |
OXTELLAR XR |
OXCARBAZEPINE |
TABLET |
ORAL |
20130117 |
N/A |
NDA |
NDA202810 |
Supernus Pharmaceuticals, Inc. |
OXCARBAZEPINE |
300 mg/1 |
5 TABLET in 1 BLISTER PACK (17772-122-10) |
| 27241-306-01 |
27241-306 |
HUMAN PRESCRIPTION DRUG |
Oxcarbazepine |
Oxcarbazepine |
TABLET, EXTENDED RELEASE |
ORAL |
20240809 |
N/A |
NDA AUTHORIZED GENERIC |
NDA202810 |
Ajanta Pharma USA Inc. |
OXCARBAZEPINE |
600 mg/1 |
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-306-01) |
| 17772-121-01 |
17772-121 |
HUMAN PRESCRIPTION DRUG |
OXTELLAR XR |
OXCARBAZEPINE |
TABLET |
ORAL |
20130117 |
N/A |
NDA |
NDA202810 |
Supernus Pharmaceuticals, Inc. |
OXCARBAZEPINE |
150 mg/1 |
100 TABLET in 1 BOTTLE (17772-121-01) |
| 17772-121-07 |
17772-121 |
HUMAN PRESCRIPTION DRUG |
OXTELLAR XR |
OXCARBAZEPINE |
TABLET |
ORAL |
20230701 |
N/A |
NDA |
NDA202810 |
Supernus Pharmaceuticals, Inc. |
OXCARBAZEPINE |
150 mg/1 |
7 TABLET in 1 BOTTLE (17772-121-07) |
| 17772-121-10 |
17772-121 |
HUMAN PRESCRIPTION DRUG |
OXTELLAR XR |
OXCARBAZEPINE |
TABLET |
ORAL |
20130117 |
N/A |
NDA |
NDA202810 |
Supernus Pharmaceuticals, Inc. |
OXCARBAZEPINE |
150 mg/1 |
5 TABLET in 1 BLISTER PACK (17772-121-10) |
| 27241-305-01 |
27241-305 |
HUMAN PRESCRIPTION DRUG |
Oxcarbazepine |
Oxcarbazepine |
TABLET, EXTENDED RELEASE |
ORAL |
20240809 |
N/A |
NDA AUTHORIZED GENERIC |
NDA202810 |
Ajanta Pharma USA Inc. |
OXCARBAZEPINE |
300 mg/1 |
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-305-01) |
| 27241-304-01 |
27241-304 |
HUMAN PRESCRIPTION DRUG |
Oxcarbazepine |
Oxcarbazepine |
TABLET, EXTENDED RELEASE |
ORAL |
20240809 |
N/A |
NDA AUTHORIZED GENERIC |
NDA202810 |
Ajanta Pharma USA Inc. |
OXCARBAZEPINE |
150 mg/1 |
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-304-01) |
| 17772-123-01 |
17772-123 |
HUMAN PRESCRIPTION DRUG |
OXTELLAR XR |
OXCARBAZEPINE |
TABLET |
ORAL |
20130117 |
N/A |
NDA |
NDA202810 |
Supernus Pharmaceuticals, Inc. |
OXCARBAZEPINE |
600 mg/1 |
100 TABLET in 1 BOTTLE (17772-123-01) |
| 17772-123-07 |
17772-123 |
HUMAN PRESCRIPTION DRUG |
OXTELLAR XR |
OXCARBAZEPINE |
TABLET |
ORAL |
20230701 |
N/A |
NDA |
NDA202810 |
Supernus Pharmaceuticals, Inc. |
OXCARBAZEPINE |
600 mg/1 |
7 TABLET in 1 BOTTLE (17772-123-07) |
| 17772-123-10 |
17772-123 |
HUMAN PRESCRIPTION DRUG |
OXTELLAR XR |
OXCARBAZEPINE |
TABLET |
ORAL |
20130117 |
N/A |
NDA |
NDA202810 |
Supernus Pharmaceuticals, Inc. |
OXCARBAZEPINE |
600 mg/1 |
5 TABLET in 1 BLISTER PACK (17772-123-10) |